Topics covered: The volatile equity markets, The slowdown of issuance, The safety aspect during drug development, The digital distribution model, The business combination, The BiTE antibody technology, New consumption (platform) trends, Multinational corporations, Growth opportunities, FDAs regulations, Energy sources, Emerging Markets, Credit markets, Cost effective products, Chinese health care
